Clinical Trials in Texas

Showing 7241-7260 of 15,101 trials

Safety and Effectiveness Study of the VEGA UV-A System for Cross-linking in Eyes With Keratoconus and Ectasia

NCT01398852

The purpose of this research study is to evaluate the long tern safety and effectiveness of cross-linking in eyes with keratoconus and ectasia.

Keratoconus and Ectasia

Topcon Medical Systems, Inc.500 participantsStarted Dec 2010

Phoenix, Arizona, United States • Atlanta, Georgia, United States • Boston, Massachusetts, United States +10 more locations

COMPLETEDPhase 255 miles

Dose Ranging Study To Assess Efficacy, Safety and Tolerability Of PF-06700841 Topical Cream In Psoriasis

NCT03850483

This is a Phase 2b, randomized, double blind, vehicle controlled, parallel group, multicenter study in participants with mild to moderate plaque psoriasis. The duration of study participation will be approximately 22 weeks, including up to a 6 week screening period, 12 week treatment period, and approximately 4 week follow up period. Approximately 280 participants are planned to be randomized into the study.

Psoriasis

Pfizer344 participantsStarted Apr 2019

Scottsdale, Arizona, United States • Scottsdale, Arizona, United States • Hot Springs, Arkansas, United States +76 more locations

Safety and Effectiveness Study of the VEGA UV-A System for Cross-linking in Eyes With Keratoconus and Ectasia

Dose Ranging Study To Assess Efficacy, Safety and Tolerability Of PF-06700841 Topical Cream In Psoriasis

Find Trials by Condition in Texas

Safety Study of the VEGA UV-A System to Treat Ectasia

Personalized Research on Diet in Ulcerative Colitis and Crohn's Disease

SHIELD II Clinical Investigation

Prevention of Non-Surgical Bleeding by Management of HeartMate II Patients Without Antiplatelet Therapy

Study to Evaluate Vadadustat for the Correction of Anemia in Participants With Non-dialysis-dependent Chronic Kidney Disease

Long-term Study of Romiplostim in Thrombocytopenic Pediatric Patients With Immune Thrombocytopenia (ITP)

Study of AGN-190584 Eye Drops to Assess Safety and Efficacy in Participants Aged 40-80 Years With Pseudophakic Presbyopia

Efficacy and Safety of Decitabine as Epigenetic Priming With Induction Chemotherapy in Pediatric Acute Myelogenous Leukemia (AML) Subjects

MOMENTUM 3 IDE Clinical Study Protocol

Thoratec HeartMate II Left Ventricular Assist System (LVAS) for Bridge to Cardiac Transplantation

MOMENTUM 3 Continued Access Protocol

Risk Assessment and Comparative Effectiveness of Left Ventricular Assist Device (LVAD) and Medical Management

Study of Nivolumab (BMS-936558) in Patients With Advanced or Metastatic Squamous Cell Nonsmall-cell Lung Cancer Who Have Received At Least 2 Prior Systemic Regimens

CentriMag Ventricular Assist System in Treating Failure-to-Wean From Cardiopulmonary Bypass

CentriMag RVAS U.S. Post-approval Study Protocol

Esteem New Subject Enrollment Post Approval Study

A Study of Two Different Dose Combinations of Nivolumab in Combination With Ipilimumab in Subjects With Previously Untreated, Unresectable or Metastatic Melanoma

Study of Reduced Anti-coagulation/Anti-platelet Therapy in Patients With the HeartMate II Left Ventricular Assist System (LVAS) (TRACE)